Top

Current Treatment Options in Gastroenterology

Content (9 Articles)

Current treatments in nonalcoholic steatohepatitis

Dawn M. Torres, Stephen A. Harrison

Treatment options in acute porphyria, porphyria cutanea tarda, and erythropoietic protoporphyria

Pauline Harper, Staffan Wahlin

Hepatitis D

Elif S. Koytak, Cihan Yurdaydin, Jeffrey S. Glenn

Coagulopathy in liver disease

Wojciech Blonski, Timothy Siropaides, K. Rajender Reddy

Treatment of hepatitis B e antigen-negative patients

Chee-Kin Hui, George K. Lau

Treatment of gastropathy and gastric antral vascular ectasia in patients with portal hypertension

Cristina Ripoll, Guadalupe Garcia-Tsao

The multiple facets of ABCB4 (MDR3) deficiency

Shikha S. Sundaram, Ronald J. Sokol

Hepatic schistosomiasis

Karin L. Andersson, Raymond T. Chung

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.